The effect of ketorolac on posterior minimally invasive transforaminal lumbar interbody fusion: an interim analysis from a randomized, double-blinded, placebo-controlled trial
Year: 2021
Type: article
Source: The Spine Journal
Authors: Chad F. Claus, Evan Lytle, Michael Lawless, Doris Tong, Diana Sigler, Lucas Garmo, Dejan Slavnic, Jacob Jasinski, Robert W. McCabe, Ascher Kaufmann, Gustavo Anton, Elise Yoon, Ammar Alsalahi, Karl Kado, Peter Bono, Daniel A. Carr, Prashant Kelkar, Clifford Houseman, Boyd Richards, Teck M. Soo
Institutions: Ascension Providence Hospital, Michigan State University
Language: English
Subfield: Orthopedics and Sports Medicine
Field: Medicine
Domain: Health Sciences
Keywords: ac, transforaminal lumbar interbody fusion, minimally invasive spine surgery, postoperative pain, opioid-sparing analgesia, bone morphogenetic proteins, fusion rate, nonunion, non-inferiority, length of hospital stay, lumbar degenerative disease, nonsteroidal anti-inflammatory drugs, postoperative complications, quality of life, Oswestry Disability Index
Open Access status: closed
Funder: National Institutes of Health
Award: G3904751602
OpenAlex ID: W3198293685
